These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6321941)

  • 1. Japanese encephalitis: report of a World Health Organization Working Group.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Mar; 33(9):119-20, 125. PubMed ID: 6321941
    [No Abstract]   [Full Text] [Related]  

  • 2. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 3. Japanese encephalitis vaccination, with reference to travellers to Seoul, Korea.
    Can Dis Wkly Rep; 1988 Sep; 14(36):161-2. PubMed ID: 2852545
    [No Abstract]   [Full Text] [Related]  

  • 4. An attenuated Japanese encephalitis vaccine.
    Inoue YK
    Prog Med Virol; 1975; 19():247-56. PubMed ID: 164051
    [No Abstract]   [Full Text] [Related]  

  • 5. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A special note on Japanese encephalitis vaccine.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Sep; 38(3):103-4. PubMed ID: 7828224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)].
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821
    [No Abstract]   [Full Text] [Related]  

  • 8. Japanese encephalitis vaccination in Thailand.
    Fukunaga T; Rojanasuphot S; Wungkorbkiat S; Thammanichanon A; Kan T
    Biken J; 1974 Mar; 17(1):21-31. PubMed ID: 4368852
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
    Guo W; Li L; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Japanese encephalitis: vaccination for some travelers to Asia useful and possible in The Netherlands].
    Kager PA
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1755-7. PubMed ID: 8396734
    [No Abstract]   [Full Text] [Related]  

  • 11. National Advisory Committee on Immunization (NACI). Statement on Japanese encephalitis vaccine.
    Can Commun Dis Rep; 1993 Oct; 19(19):160-4. PubMed ID: 8251988
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
    Luo D; Yin H; Xili L; Song J; Wang Z
    Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese encephalitis revisited.
    Diagana M; Preux PM; Dumas M
    J Neurol Sci; 2007 Nov; 262(1-2):165-70. PubMed ID: 17643451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost benefit analysis of Japanese encephalitis vaccination program in Thailand.
    Siraprapasiri T; Sawaddiwudhipong W; Rojanasuphot S
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):143-8. PubMed ID: 9322297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy.
    Wierzba TF; Ghimire P; Malla S; Banerjee MK; Shrestha S; Khanal B; Sedai TR; Gibbons RV
    Am J Trop Med Hyg; 2008 Jun; 78(6):1002-6. PubMed ID: 18541784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statement on protection against Japanese encephalitis. An Advisory Committee Statement (ACS).
    Committee to Advise on Tropical Medicine and Travel (CATMAT)
    Can Commun Dis Rep; 2008 Sep; 34(ACS-4):1-14. PubMed ID: 18841582
    [No Abstract]   [Full Text] [Related]  

  • 18. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.
    Ferguson M; Kurane I; Wimalaratne O; Shin J; Wood D;
    Vaccine; 2007 Jul; 25(29):5233-43. PubMed ID: 17590244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should vaccination be a priority approach for Japanese encephalitis prevention in Nepal?
    Joshi AB; Banjara MR; Wierzba T
    JNMA J Nepal Med Assoc; 2005; 44(157):31. PubMed ID: 16152681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.